<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01872338</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 12-134</org_study_id>
    <nct_id>NCT01872338</nct_id>
  </id_info>
  <brief_title>Mindfulness-Based Cognitive Therapy for Suicide Prevention</brief_title>
  <acronym>MBCT-S</acronym>
  <official_title>Mindfulness-Based Cognitive Therapy for Preventing Suicide in Military Veterans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rutgers University Bloustein Center for Survey Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test a psychotherapeutic intervention that integrates
      cognitive therapy and mindfulness meditation techniques to prevent suicide in military
      Veterans.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Every month the VA becomes aware of approximately 1,100 Veterans in VA care who attempt
      suicide. While the VA has implemented a comprehensive, multifaceted suicide prevention
      approach, it has yet to implement nationally any evidence-based psychotherapies targeting
      suicide, a gap due largely to the dearth of evidence-based therapies for suicide. Primary
      aims of this proposal are to conduct a randomized controlled trial testing an adaptation of a
      cognitive-behavioral intervention, Mindfulness-Based Cognitive Therapy (MBCT), for Veterans
      on the VA's High Risk for Suicide List. The investigators' adapted version of MBCT for
      suicide (MBCT-S) integrates mindfulness meditation techniques with the VA Safety Plan to
      enhance patients' awareness of suicide triggers and appropriate coping strategies. This study
      has the potential to increase the range of cost effective treatment alternatives for the
      large number of suicidal Veterans for whom evidence-based therapies are severely limited.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2013</start_date>
  <completion_date type="Actual">April 3, 2019</completion_date>
  <primary_completion_date type="Actual">April 3, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Suicide Event</measure>
    <time_frame>12-months post-baseline</time_frame>
    <description>The investigators define &quot;event&quot; broadly as a range of suicidal behaviors defined according to the VA's Self-Directed Violence Classification System (SDVCS). Based on the SDVCS, an event may include self-directed violence, with or without injury, in which evidence of suicidal intent is clear or undetermined; or suicidal preparatory behaviors. The study definition of a suicide event also includes suicidal ideation resulting in the need for emergency care or psychiatric hospitalization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Suicide Attempt</measure>
    <time_frame>12 months post-baseline</time_frame>
    <description>Defined as deliberate self-directed violence with injury or potential for injury and with explicit/implicit suicidal intent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicidal Ideation</measure>
    <time_frame>Baseline, 4 weeks (mid-treatment), 8 weeks (treatment-completion), 6 months and 12-months post-baseline</time_frame>
    <description>clinician-administered Scale for Suicide Ideation (SSI), 0-38, higher score = higher suicidal ideation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hopelessness</measure>
    <time_frame>Baseline, 4 weeks (mid-treatment), 8 weeks (treatment-completion), 6 months and 12-months post-baseline</time_frame>
    <description>Hopelessness will be measured using the Beck Hopelessness Scale, score range 0-20, with higher scores indicating more hopelessness.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">135</enrollment>
  <condition>Suicide</condition>
  <arm_group>
    <arm_group_label>Mindfulness-Based Cognitive Therapy + Treatment As Usual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment As Usual</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>VA standard care for suicide prevention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness-Based Cognitive Therapy for Suicide</intervention_name>
    <description>Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.</description>
    <arm_group_label>Mindfulness-Based Cognitive Therapy + Treatment As Usual</arm_group_label>
    <other_name>MBCT-S</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Treatment as usual</intervention_name>
    <description>VA standard care for suicide prevention</description>
    <arm_group_label>Treatment As Usual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The following criteria were formulated to recruit a sample at high risk for suicide
        behavior.

          -  The subject has experienced a suicidal event during the past 30 days. A suicidal event
             involves

               -  1) psychiatric hospitalization due to suicidal risk,

               -  2) psychiatric hospitalization if subject was already on the High Risk for
                  Suicide List,

               -  3) suicidal ideation with suicidal intent,

               -  4) suicidal preparatory behaviors, or

               -  5) actual, interrupted, or aborted suicide attempt.

        AND

          -  The subject is on or will be placed on the VA High Risk for Suicide List

               -  OR The subject had an actual, interrupted, or aborted attempt in the last year

               -  OR In the study clinician's opinion (i.e., Masters or Doctoral level study
                  personnel with formal mental health training) in consultation with the PI, the
                  suicidal event is significant enough to warrant treatment to reduce suicidal
                  risk.

        Exclusion Criteria:

          -  cognitive deficits that decrease the likelihood of benefit from MBCT-S

          -  severe symptoms of hallucinations or delusions

          -  disorganized or disruptive behaviors

          -  medically unstable

          -  current mindfulness-based psychotherapy or receipt of 2 or more sessions of a
             mindfulness-based psychotherapy in the last 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alejandro Interian, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lyons Campus of the VA New Jersey Health Care System, Lyons, NJ</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ</name>
      <address>
        <city>East Orange</city>
        <state>New Jersey</state>
        <zip>07018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lyons Campus of the VA New Jersey Health Care System, Lyons, NJ</name>
      <address>
        <city>Lyons</city>
        <state>New Jersey</state>
        <zip>07939</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>May 10, 2013</study_first_submitted>
  <study_first_submitted_qc>June 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2013</study_first_posted>
  <results_first_submitted>April 8, 2020</results_first_submitted>
  <results_first_submitted_qc>April 8, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 22, 2020</results_first_posted>
  <last_update_submitted>April 22, 2020</last_update_submitted>
  <last_update_submitted_qc>April 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>suicide prevention</keyword>
  <keyword>mindfulness-based cognitive therapy</keyword>
  <keyword>mindfulness meditation</keyword>
  <keyword>Veterans</keyword>
  <keyword>safety planning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Suicide</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 14, 2013</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/38/NCT01872338/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Mindfulness-Based Cognitive Therapy + Treatment As Usual</title>
          <description>Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.
Mindfulness-Based Cognitive Therapy for Suicide: Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.</description>
        </group>
        <group group_id="P2">
          <title>Treatment As Usual</title>
          <description>VA standard care for suicide prevention
Treatment as usual: VA standard care for suicide prevention</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="69"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="69"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Mindfulness-Based Cognitive Therapy + Treatment As Usual</title>
          <description>Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.
Mindfulness-Based Cognitive Therapy for Suicide: Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.</description>
        </group>
        <group group_id="B2">
          <title>Treatment As Usual</title>
          <description>VA standard care for suicide prevention
Treatment as usual: VA standard care for suicide prevention</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="66"/>
            <count group_id="B2" value="69"/>
            <count group_id="B3" value="135"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.54" spread="13.2"/>
                    <measurement group_id="B2" value="45.97" spread="14.3"/>
                    <measurement group_id="B3" value="46.96" spread="11.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>RACE/ETHNICITY</title>
              <category_list>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian, American Indian, or other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Suicide Attempt History</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>none</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>one</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>multiple</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Suicide Event</title>
        <description>The investigators define &quot;event&quot; broadly as a range of suicidal behaviors defined according to the VA's Self-Directed Violence Classification System (SDVCS). Based on the SDVCS, an event may include self-directed violence, with or without injury, in which evidence of suicidal intent is clear or undetermined; or suicidal preparatory behaviors. The study definition of a suicide event also includes suicidal ideation resulting in the need for emergency care or psychiatric hospitalization.</description>
        <time_frame>12-months post-baseline</time_frame>
        <population>Total number of suicidal events within the 12-month observation period by study condition.</population>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy + Treatment As Usual</title>
            <description>Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.
Mindfulness-Based Cognitive Therapy for Suicide: Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.</description>
          </group>
          <group group_id="O2">
            <title>Treatment As Usual</title>
            <description>VA standard care for suicide prevention
Treatment as usual: VA standard care for suicide prevention</description>
          </group>
        </group_list>
        <measure>
          <title>Suicide Event</title>
          <description>The investigators define &quot;event&quot; broadly as a range of suicidal behaviors defined according to the VA's Self-Directed Violence Classification System (SDVCS). Based on the SDVCS, an event may include self-directed violence, with or without injury, in which evidence of suicidal intent is clear or undetermined; or suicidal preparatory behaviors. The study definition of a suicide event also includes suicidal ideation resulting in the need for emergency care or psychiatric hospitalization.</description>
          <population>Total number of suicidal events within the 12-month observation period by study condition.</population>
          <units>count of events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="69"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.015</p_value>
            <method>negative binomial regression</method>
            <param_type>Incident Rate Ratio</param_type>
            <param_value>.50</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.29</ci_lower_limit>
            <ci_upper_limit>.87</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Suicide Attempt</title>
        <description>Defined as deliberate self-directed violence with injury or potential for injury and with explicit/implicit suicidal intent</description>
        <time_frame>12 months post-baseline</time_frame>
        <population>count of suicide attempts over 12-month period by study condition</population>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy + Treatment As Usual</title>
            <description>Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.
Mindfulness-Based Cognitive Therapy for Suicide: Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.</description>
          </group>
          <group group_id="O2">
            <title>Treatment As Usual</title>
            <description>VA standard care for suicide prevention
Treatment as usual: VA standard care for suicide prevention</description>
          </group>
        </group_list>
        <measure>
          <title>Suicide Attempt</title>
          <description>Defined as deliberate self-directed violence with injury or potential for injury and with explicit/implicit suicidal intent</description>
          <population>count of suicide attempts over 12-month period by study condition</population>
          <units>count of suicide attempts</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="69"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.01</p_value>
            <method>negative binomial regression</method>
            <param_type>Incident Rate Ratio</param_type>
            <param_value>.43</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.22</ci_lower_limit>
            <ci_upper_limit>.82</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Suicidal Ideation</title>
        <description>clinician-administered Scale for Suicide Ideation (SSI), 0-38, higher score = higher suicidal ideation.</description>
        <time_frame>Baseline, 4 weeks (mid-treatment), 8 weeks (treatment-completion), 6 months and 12-months post-baseline</time_frame>
        <population>Linear mixed models, examining change from baseline over 12 months (5 assessments total), with effect of interest being time*cond interaction.</population>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy + Treatment As Usual</title>
            <description>Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.
Mindfulness-Based Cognitive Therapy for Suicide: Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.</description>
          </group>
          <group group_id="O2">
            <title>Treatment As Usual</title>
            <description>VA standard care for suicide prevention
Treatment as usual: VA standard care for suicide prevention</description>
          </group>
        </group_list>
        <measure>
          <title>Suicidal Ideation</title>
          <description>clinician-administered Scale for Suicide Ideation (SSI), 0-38, higher score = higher suicidal ideation.</description>
          <population>Linear mixed models, examining change from baseline over 12 months (5 assessments total), with effect of interest being time*cond interaction.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="69"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Time 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.4" spread="1.2"/>
                    <measurement group_id="O2" value="11.2" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.8" spread="1.2"/>
                    <measurement group_id="O2" value="6.1" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="1.1"/>
                    <measurement group_id="O2" value="4.7" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1" spread="1.1"/>
                    <measurement group_id="O2" value="3.3" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread=".9"/>
                    <measurement group_id="O2" value="2.3" spread=".8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.34</p_value>
            <method>Regression, Linear</method>
            <method_desc>repeated measures, overall time by condition effect</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hopelessness</title>
        <description>Hopelessness will be measured using the Beck Hopelessness Scale, score range 0-20, with higher scores indicating more hopelessness.</description>
        <time_frame>Baseline, 4 weeks (mid-treatment), 8 weeks (treatment-completion), 6 months and 12-months post-baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy + Treatment As Usual</title>
            <description>Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.
Mindfulness-Based Cognitive Therapy for Suicide: Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.</description>
          </group>
          <group group_id="O2">
            <title>Treatment As Usual</title>
            <description>VA standard care for suicide prevention
Treatment as usual: VA standard care for suicide prevention</description>
          </group>
        </group_list>
        <measure>
          <title>Hopelessness</title>
          <description>Hopelessness will be measured using the Beck Hopelessness Scale, score range 0-20, with higher scores indicating more hopelessness.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="69"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Time 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.4" spread=".7"/>
                    <measurement group_id="O2" value="11.8" spread=".7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread=".9"/>
                    <measurement group_id="O2" value="8.1" spread=".8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" spread=".9"/>
                    <measurement group_id="O2" value="8.3" spread=".9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" spread=".9"/>
                    <measurement group_id="O2" value="7.7" spread=".9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" spread="1.0"/>
                    <measurement group_id="O2" value="8.6" spread=".9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.23</p_value>
            <p_value_desc>repeated measures, overall time by condition effect</p_value_desc>
            <method>Regression, Linear</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12-month study participation period</time_frame>
      <desc>all serious adverse events were reported to IRB and reviewed by a DSMB</desc>
      <group_list>
        <group group_id="E1">
          <title>Mindfulness-Based Cognitive Therapy + Treatment As Usual</title>
          <description>Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.
Mindfulness-Based Cognitive Therapy for Suicide: Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.</description>
        </group>
        <group group_id="E2">
          <title>Treatment As Usual</title>
          <description>VA standard care for suicide prevention
Treatment as usual: VA standard care for suicide prevention</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Medical SAE</sub_title>
                <description>**no adverse events were determined by IRB to be related to the research procedures or intervention</description>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="66"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Medical SAE</sub_title>
                <description>**no adverse events were determined by IRB to be related to the research procedures or intervention</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="66"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Medical SAE</sub_title>
                <description>**no adverse events were determined by IRB to be related to the research procedures or intervention</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="66"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Medical SAE</sub_title>
                <description>**no adverse events were determined by IRB to be related to the research procedures or intervention</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Medical SAE</sub_title>
                <description>**no adverse events were determined by IRB to be related to the research procedures or intervention</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Medical SAE</sub_title>
                <description>**no adverse events were determined by IRB to be related to the research procedures or intervention</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Medical SAE</sub_title>
                <description>**no adverse events were determined by IRB to be related to the research procedures or intervention</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="66"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychatric Adverse Events</sub_title>
                <counts group_id="E1" events="45" subjects_affected="26" subjects_at_risk="66"/>
                <counts group_id="E2" events="85" subjects_affected="37" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Medical SAE</sub_title>
                <description>**no adverse events were determined by IRB to be related to the research procedures or intervention</description>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>SAE Other</sub_title>
                <description>**no adverse events were determined by IRB to be related to the research**</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Medical SAE</sub_title>
                <description>**no adverse events were determined by IRB to be related to the research procedures or intervention</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="66"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Medical SAE</sub_title>
                <description>**no adverse events were determined by IRB to be related to the research procedures or intervention</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychiatric other (not including serious)</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="66"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alejandro Interian, PHD</name_or_title>
      <organization>VA New Jersey Healthcare System</organization>
      <phone>908-647-0180 ext 4617</phone>
      <email>alejandro.interian@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

